
Pharmacally
Antibody-Helicon Conjugates
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Antibody-Helicon Conjugates
Mergers & AcquisitionsRegeneron and Parabilis Partner to Develop Antibody-Helicon ConjugatesRegeneron partnered with Parabilis Medicines to develop Antibody-Helicon Conjugates, investigational therapies that combine antibody targeting with intracellular Helicon peptide delivery for historically “undruggable” proteins.Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.